The German defence group TKMS found itself caught between two very different government schedules last week. Minutes after the Bundestag’s budget committee gave the green light on July 8 for four new frigates for the German Navy — a firm order with an option for additional vessels — investors were already looking across the Atlantic to Canada, where a far larger submarine deal is moving at a slower pace than the company would like.
The immediate market reaction was telling. On Friday, TKMS shares closed at €81.70, down 4.22% on the day. That single-session decline, which the secondary source attributes squarely to the widening gap between CEO Oliver Burkhard’s ambition to sign Canada’s submarine contract by end-2026 and Ottawa’s more deliberate target of late 2027, erased some of the euphoria built up since the company was named preferred bidder over South Korea’s Hanwha Ocean.
Yet the frigate approval underscores why TKMS describes itself as a “maritime powerhouse.” The shipbuilder’s order backlog already stood at €20.6 billion at the halfway point of fiscal 2025/26, and the new German contract — plus the subsequent option — will push that figure higher. That cushion, management argues, provides planning security in a sector prone to political shocks.
The numbers support the bullish narrative. TKMS shares have gained 17.98% since the start of 2026 and remain 13.47% higher over the past 30 days, despite Friday’s setback. The current price sits 43.96% above the 52-week low of €56.75 touched in November 2025, confirming a long-term uptrend that has been intact since autumn. The relative strength index reads 51.0 — neutral territory, leaving room for movement in either direction.
But the market’s patience is being tested by the sheer size of what is at stake in Ottawa. The Canadian submarine programme is the largest single order in TKMS history, covering 24 Type 212CD boats to be built entirely at the company’s domestic yards in Kiel and the newly integrated site in Wismar. Until a legally binding contract is signed, however, the deal remains a political declaration — and Canada has kept a fallback option open to reopen talks with Hanwha should the TKMS negotiations stall.
Should investors sell immediately? Or is it worth buying TKMS?
That uncertainty is amplified by the stock’s annualised volatility of 82.25%, a level typical for defence names whose fortunes swing with headlines from Berlin, Ottawa and beyond. The current price is still 20.60% below the 52-week high of €102.90 set on 26 January, when the first wave of Canada-related optimism peaked. With the Canadian government working to its own timetable, the risk of further disappointment persists.
On the positive side, TKMS reaffirmed its full-year guidance in May 2026. The company expects revenue growth of 2% to 5% compared with the prior year, together with an adjusted EBIT margin above 6% — and a medium-term target of more than 7%. The frigate order directly supports that margin trajectory, offering multi-year visibility that does not depend on the Canadian timeline.
Chart watchers have their eyes on the 50-day moving average at €78.70, which currently sits 3.81% below the closing price. A hold above that level would keep the medium-term uptrend intact; a breach would strengthen the bearish case and could trigger a test of lower supports. The next major catalyst comes in August, when TKMS reports nine-month results for fiscal 2025/26 and is expected to offer firmer data on margins and cash flow.
For now, TKMS shares remain a play on two very different clock speeds: the dependable rhythm of German defence procurement and the unpredictable dance of transatlantic negotiations. Until one of those timetables delivers concrete financial impact, the stock is likely to swing with every political signal that emerges from Ottawa.
Ad
TKMS Stock: Buy or Sell?! New TKMS Analysis from July 11 delivers the answer:
The latest TKMS figures speak for themselves: Urgent action needed for TKMS investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 11.
TKMS: Buy or sell? Read more here...
